Welcome to our dedicated page for Jack Nathan Med news (Ticker: JNHMF), a resource for investors and traders seeking the latest updates and insights on Jack Nathan Med stock.
Jack Nathan Medical Corp. (JNHMF), operating as Jack Nathan Health, is frequently in the news for its operational restructuring, financial results, and strategic decisions. Company press releases highlight its transition from managing a large retail medical clinic network in Canada and Mexico to focusing on MedSpa services in Canada. News coverage often centers on how these changes affect its continuing operations and financial position.
Recent announcements describe the sale of Jack Nathan Health’s Canadian primary care clinic and licensee business to WELL Health Technologies Corp., the closure of its Mexico clinic network following the termination of its agreement with Walmart Mexico, and the resulting focus on Canadian MedSpa clinics. Financial results releases provide details on revenues from continuing MedSpa operations, discontinued operations related to Canada and Mexico, and the impact of restructuring on losses or income from continuing and discontinued segments.
Investors following JNHMF news will also see updates on audit timing, filing deadlines, and regulatory matters. The company has reported delays in filing audited annual financial statements and interim results, as well as the issuance of a Failure-to-File Cease Trade Order by the Ontario Securities Commission and its subsequent efforts to complete required filings. In addition, management commentary in news releases discusses strategic options, including evaluating future opportunities for the business in Canada and other markets.
This news feed aggregates company-issued releases so readers can review Jack Nathan Health’s financial disclosures, operational updates, and strategic announcements in one place. For those tracking JNHMF, the news page offers a way to monitor how the company’s MedSpa-focused strategy, restructuring activities, and going concern disclosures evolve over time.
Jack Nathan Medical Corp (TSXV: JNH; Pink: JNHMF) announced a leadership transition on January 23, 2026. Mike Marchelletta is stepping down as CEO and vice-chairman to lead a prospective investor syndicate evaluating a potential strategic transaction; there is no assurance a transaction will complete. Michael Di Cesare, co-founder and former COO, is appointed Interim CEO and vice-chairman to provide operational continuity. Mr. Marchelletta agreed to a four-month lock-up on 21,000,000 common shares, temporary assignment of those voting rights to Mr. Di Cesare as trustee, ongoing voting support, and voluntary deferral of executive compensation. The company said it eliminated approximately $15 million of debt and cancelled about 140 million common shares previously issuable under legacy debenture arrangements.
Jack Nathan Health (OTCID: JNHMF) reported Q2 fiscal 2026 financial results, marking significant operational changes. The company announced the complete closure of its Mexico operations following termination of its Walmart Mexico agreement, shifting focus entirely to its Canadian MedSpa business.
Q2 financial highlights include revenue of $227,532, down from $264,546 in Q2 2024. Six-month revenue reached $412,791, a 14% decrease from the previous year's $471,548. Operating expenses improved to $709,698 from $1,088,630 year-over-year. The company maintains $0.80 million in cash and operates four MedSpa clinics across Alberta and Ontario.
Management expects to reach breakeven by year-end through cost restructuring and a leaner business model focused on Canadian operations.
Jack Nathan Health (OTCQB: JNHMF) reported its Q1 fiscal 2026 financial results, marking a transitional period following significant corporate restructuring. The company posted revenues of $1.99 million, down 4% year-over-year, with MedSpa revenues at $185,259 representing 9% of total revenue.
The company reported a loss from operations of $830,959, compared to $684,936 in the prior year. As of April 30, 2025, Jack Nathan Health maintained cash reserves of $0.91 million, down from $2.2 million in January 2025, with total assets of $2.65 million and total liabilities of $2.45 million.
Notably, the company has completely ceased operations in Mexico as of June 30, 2025, following the termination of its Walmart Mexico agreement, and is now focusing on building its MedSpa platform in Canada after divesting its Canadian medical clinic and licensee business in December 2024.
Jack Nathan Health (OTCQB: JNHMF) has released its Q4 and fiscal year 2025 financial results, marking a significant transitional period. The company reported total consolidated revenues of $19.1 million, with continuing operations revenue increasing 26% to $8.7 million. Notable highlights include MedSpa revenue growth of 90% year-over-year to $1.03 million.
The company completed two major strategic exits: the divestiture of its Canadian primary care and licensee business, resulting in a $16.4 million gain, and the cessation of Mexico operations as of June 30, 2025. The company's balance sheet shows cash of $2.2 million and improved working capital of $1.4 million, compared to a previous deficit of $0.5 million.
Jack Nathan Medical Corp (TSXV: JNH; OTCQB: JNHMF) announces critical developments regarding its Mexico operations. The company has been unable to reach an agreement with Walmart Mexico for business continuity of its 171 healthcare facilities within Walmart Mexico stores and distribution centres.
Following unsuccessful negotiations, Walmart Mexico has issued termination notices, with operations expected to cease by May 31, 2025. The company is actively exploring strategic alternatives, including:
- Selling Mexico operations to a successor
- Establishing partnerships with new retail and corporate entities
- Potential mergers and acquisitions
A comprehensive data room will be available to qualified interested parties. Without securing a new agreement or M&A transaction, JNH faces a potential wind-down of its Mexican operations.
Jack Nathan Medical Corp (TSXV: JNH; OTCQB: JNHMF) announces strategic evaluation of its Mexico operations due to challenges with Walmart Mexico partnership. The company is exploring multiple options for its 171 facilities within Walmart Mexico stores including:
- Potential sale to a successor or competing medical operator
- Renegotiation of business terms with Walmart Mexico
- Development of a bilateral transition plan
While the company has secured a profit-sharing agreement with Walmart Canada effective December 1, 2024, failure to reach an agreement in Mexico could lead to a potential wind-down of Mexican operations. The company is also exploring partnerships with other retail and corporate entities as alternatives. A comprehensive data room will be available to qualified interested parties for due diligence.
Jack Nathan Health (JNHMF) reported Q3 fiscal 2025 results with revenue growth of 16% year-to-date, reaching $15.9M compared to $13.7M in 2023. The company's Mexican operations, which added 7 new clinics during Q3 bringing the total to 168 corporate-owned clinics, drove this growth. Clinic operations generated 89% of total revenues at $4.7M for Q3.
The company reported an operating loss of $4.5M for the nine months ended October 31, 2024, up from $3.8M in 2023. Post-quarter, the company completed the sale of its Canadian operations to WELL Health Technologies for $5M, resulting in the elimination of over $15M in debt owed to Wal-Mart Canada Corp. The company now focuses on Mexican operations and MedSpa sector expansion.
Jack Nathan Health has completed the sale of its Canadian business to WELL Health Technologies for Cdn$5,000,000. The transaction eliminates over Cdn$15 million in debt owed to Wal-Mart Canada Corp. The company retains its Mexican operations, including 155 corporate-owned clinics in Walmart locations, five clinics in Walmart distribution centers, and one multidisciplinary clinic. The deal includes a profit-sharing agreement with Walmart, granting them 10% interest in the first year and 25% thereafter until Cdn$4 million is paid. Following the transaction, Dr. Glenn Copeland and Marcy Herriman have stepped down from their executive positions, with Mike Marchelletta assuming the role of CEO.
Jack Nathan Medical Corp. (TSXV: JNH; OTCQB: JNHMF) has agreed to sell its Canadian business to WELL Health Technologies for Cdn$5,000,000 in cash. The deal includes the extinguishment of over Cdn$15,000,000 debt owed to Wal-Mart Canada. Post-transaction, the company will retain its Mexican operations, including 155 Walmart-based clinics, 5 distribution center clinics, and 1 multidisciplinary clinic. WELL is providing an interim credit facility of up to $750,000 at 12% interest. The deal requires shareholder approval, with 24.36% of shareholders already committed. As part of the agreement, JN Mexico will share 10% of profits in year one and 25% thereafter with Walmart, until Cdn$4 million is paid.
FAQ
What is the current stock price of Jack Nathan Med (JNHMF)?
What is the market cap of Jack Nathan Med (JNHMF)?
